John W Smither is a director of NewAmsterdam Pharma Company NV.
Person profile
Roles
Address
Calabasas, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
144
Arcutis Biotherapeutics, Inc.
26 Jun 24
4
GENELUX Corp
7 Jun 24
144
Arcutis Biotherapeutics, Inc.
17 May 24
4
Arcutis Biotherapeutics, Inc.
15 Feb 24
4
NewAmsterdam Pharma Co N.V.
3 Jan 24
3
NewAmsterdam Pharma Co N.V.
29 Dec 23
4
Applied Molecular Transport Inc.
28 Dec 23
4
GENELUX Corp
14 Sep 23
4
GENELUX Corp
13 Sep 23
3
GENELUX Corp
13 Sep 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 May 24 | GNLX Genelux | Common Stock | Buy | Acquire P | No | No | 0 | 6,250 | 0.00 | 13,170 |
29 May 24 | GNLX Genelux | Common Stock Warrant Common Stock | Buy | Acquire P | No | No | 5.25 | 6,250 | 32.81 k | 6,250 |
13 Feb 24 | ARQT Arcutis Biotherapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 8,572 | 0.00 | 11,365 |
13 Feb 24 | ARQT Arcutis Biotherapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 2,793 | 0.00 | 2,793 |
13 Feb 24 | ARQT Arcutis Biotherapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 32.44 | 25,718 | 834.29 k | 0 |
13 Feb 24 | ARQT Arcutis Biotherapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 27.61 | 8,379 | 231.34 k | 0 |
1 Jan 24 | NAMS NewAmsterdam Pharma | Option Ordinary Shares | Grant | Acquire A | No | No | 11.17 | 10,000 | 111.70 k | 10,000 |
27 Dec 23 | AMTI Applied Molecular Transport | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.34 | 20,000 | 6.80 k | 0 |
27 Dec 23 | AMTI Applied Molecular Transport | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.01 | 60,000 | 480.60 k | 0 |
24 May 22 | AMTI Applied Molecular Transport | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 3.13 | 20,000 | 62.60 k | 0 |